Literature DB >> 24497766

Pyoderma gangrenosum: A case report of bilateral dorsal hand lesions and literature review of management.

Donald S Mowlds1, Jeff J Kim1, Patrick Murphy1, Garrett A Wirth1.   

Abstract

Pyoderma gangrenosum is a great masquerader in wound diagnosis and management. Frequently misdiagnosed as a necrotizing infection, the elusive nature of its etiology and pathogenesis has thwarted the establishment of a standardized management algorithm, leaving immunosuppressant therapies as the mainstay of treatment. The present report describes a 61-year-old woman presenting with temporally discrete bilateral dorsal hand lesions successfully managed with distinctive multimodality therapies. The initial lesion was managed under the auspices of a necrotizing process using a combination of hyperbaric oxygen therapy and skin grafting with a negative-pressure dressing, both individually demonstrated to be effective for prompt wound stabilization and coverage. A subsequent contralateral hand lesion was similarly managed as a necrotizing infection before a diagnosis of pyoderma gangrenosum was considered. Stabilization and eventual resolution was achieved using intravenous and topical steroids followed by hyperbaric oxygen therapy, again highlighting the benefits of multimodality therapy in the setting of pyoderma gangrenosum.

Entities:  

Keywords:  Hyperbaric oxygen therapy; Immunosuppressants; Management; Negative pressure therapy; Pyoderma gangrenosum

Year:  2013        PMID: 24497766      PMCID: PMC3910530     

Source DB:  PubMed          Journal:  Can J Plast Surg        ISSN: 1195-2199


  23 in total

Review 1.  Pyoderma gangrenosum.

Authors:  N M Blitz; D Rudikoff
Journal:  Mt Sinai J Med       Date:  2001 Sep-Oct

2.  Improvement of ulcerative pyoderma gangrenosum with hyperbaric oxygen therapy.

Authors:  Elias E Mazokopakis; Diamantis P Kofteridis; Alexia Th Pateromihelaki; Sotirios D Vytiniotis; Pantelis G Karastergiou
Journal:  Dermatol Ther       Date:  2011 Jan-Feb       Impact factor: 2.851

3.  Stabilization of pyoderma gangrenosum ulcer with oral cyclosporine prior to skin grafting.

Authors:  Mohammed Zakhireh; W Bradford Rockwell; Richard H Fryer
Journal:  Plast Reconstr Surg       Date:  2004-04-15       Impact factor: 4.730

Review 4.  Mechanisms and clinical applications of the vacuum-assisted closure (VAC) Device: a review.

Authors:  Mark L Venturi; Christopher E Attinger; Ali N Mesbahi; Christopher L Hess; Katherine S Graw
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

5.  Managing pyoderma gangrenosum: a synergistic approach combining surgical débridement, vacuum-assisted closure, and hyperbaric oxygen therapy.

Authors:  Jeffrey A Niezgoda; E Bernadette Cabigas; Heidi K Allen; John P Simanonok; Eric P Kindwall; James Krumenauer
Journal:  Plast Reconstr Surg       Date:  2006-02       Impact factor: 4.730

Review 6.  Treatment of pyoderma gangrenosum.

Authors:  R K Chow; V C Ho
Journal:  J Am Acad Dermatol       Date:  1996-06       Impact factor: 11.527

7.  Hyperbaric oxygen therapy for pyoderma gangrenosum.

Authors:  C Y Thomas; J A Crouch; J Guastello
Journal:  Arch Dermatol       Date:  1974-09

Review 8.  Etiology and management of pyoderma gangrenosum: a comprehensive review.

Authors:  Iris Ahronowitz; Joanna Harp; Kanade Shinkai
Journal:  Am J Clin Dermatol       Date:  2012-06-01       Impact factor: 7.403

9.  Pyoderma gangrenosum: skin grafting after preparation with hyperbaric oxygen.

Authors:  J C Davis; J M Landeen; R A Levine
Journal:  Plast Reconstr Surg       Date:  1987-02       Impact factor: 4.730

10.  Pyoderma gangrenosum treated with hyperbaric oxygen therapy.

Authors:  V Wasserteil; S Bruce; S L Sessoms; K K Guntupalli
Journal:  Int J Dermatol       Date:  1992-08       Impact factor: 2.736

View more
  1 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.